Deal Details

Sale to Becton, Dickinson and Company

---

Summary

About

CUBEX LLC (“CUBEX”) has successfully completed the sale of its Medical Division to Becton, Dickinson and Company (“BD” or the “Company”) (NYSE: BDX). Terms of the transaction were not disclosed.

CUBEX is a global provider of innovative health care automation and cloud-hosted business intelligence solutions that improve medication care, cost and patient outcomes for human and animal healthcare facilities,?while at the same time increasing regulatory compliance. The Medical Division of CUBEX's key offering is a cloud-based software that supports decentralized medication management and provides unique features specialized for pharmacists and nurses across the care continuum. CUBEX is headquartered in Phoenix, Arizona.

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The Company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. BD is headquartered in Franklin Lakes, New Jersey.

---

CONTACT US TO LEARN MORE